Clinical Trial

A Study to Evaluate the Safety and Pharmacokinetics of AD-118 and AD-1181 in Healthy Adult Subjects

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated March 17, 2026 (before its estimated May 2026 completion). Its status may not reflect the trial's current state.
Summary
A Study to Evaluate the Safety and Pharmacokinetics of AD-118 and AD-1181 Under Fasted Conditions in Healthy Adult Subjects
Trial Details
NCT Number NCT07476157
Lead Sponsor Addpharma Inc.
Conditions Chronic Heart Failure
Enrollment 70 participants
Start Date 2026-04
Primary Completion 2026-05 (estimated)
Study Completion 2026-05 (estimated)
Updated on ClinicalTrials.gov 2026-03-17